TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

CALCIUM GLUCONATE IN SODIUM CHLORIDE

CALCIUM GLUCONATE
Approved 2017-06-15
4
Indications
--
Phase 3 Trials
8
Years on Market

Details

Status
Discontinued
First Approved
2017-06-15
Routes
INTRAVENOUS
Dosage Forms
SOLUTION

CALCIUM GLUCONATE IN SODIUM CHLORIDE Approval History

Loading approval history...

What CALCIUM GLUCONATE IN SODIUM CHLORIDE Treats

4 FDA approvals

Originally approved for its first indication in 2017 . Covers 4 distinct patient populations.

  • Other (4)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CALCIUM GLUCONATE IN SODIUM CHLORIDE FDA Label Details

Pro

CALCIUM GLUCONATE IN SODIUM CHLORIDE Patents & Exclusivity

Latest Patent: Jul 2037

Patents (22 active)

US10130646 Expires Jul 25, 2037
US10342813 Expires Jul 25, 2037
+ 12 more patents
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.